You are currently viewing Generative AI In Medicine Market CAGR Of 43.4% Forecast For 2026–2030: What It Means For The Industry
Generative AI In Medicine Market Analysis

Designed to make market research more actionable and strategically valuable, The Business Research Company’s 2026 market reports feature market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.

Generative AI In Medicine Market To Expand At A 43.4% CAGR: Size And Growth Projections Through 2030

The generative AI in medicine market size has observed substantial growth over recent years. It is anticipated to expand from $0.95 billion in 2025 to $1.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 43.7%. This past growth can be attributed to various factors such as enhancements in medical imaging technologies, a surge in AI adoption across hospitals and clinics, an increase in clinical research projects, the rising need for personalized medical treatments, and the development of tools to improve electronic health records (EHR).

The generative AI in medicine market is projected for significant growth in the coming years. Its valuation is anticipated to reach $5.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 43.4%. This expansion during the forecast period can be attributed to several factors, including the increased adoption of AI-assisted drug discovery solutions, the integration of generative AI into treatment planning, a rise in the use of virtual nursing assistants, the embrace of robot-assisted AI surgery, and advancements in predictive patient data analytics. Key trends driving this period encompass AI-driven diagnostic tools, tailored treatment strategies, virtual nursing assistants, robot-assisted AI surgery, and comprehensive patient data analysis coupled with predictive healthcare.

Get Your Free Generative AI In Medicine Market Report Sample Today:

https://thebusinessresearchcompany.com/sample_request?id=93714154&type=smp&name=Generative%20AI%20In%20Medicine%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Which Factor Is Expected To Drive The Generative AI In Medicine Market Over The Forecast Period?

The anticipated increase in digital health records is projected to drive the expansion of the generative artificial intelligence (AI) in medicine market in the future. Digital health records, also known as electronic health records (EHRs), are organized digital compilations of patient health data that facilitate information exchange across various healthcare environments, thereby enhancing both the efficiency and standard of patient care. This rise in digital health records is fueled by factors such as better patient care, greater operational efficiency in healthcare provision, governmental backing and incentives, technological progress, and a boost in patient involvement and autonomy. Medical artificial intelligence (AI) improves digital health records by automating data entry, organizing information, offering forecasting insights, and creating tailored summaries, which in turn boosts their precision, availability, and comprehensive patient care. As an illustration, the European Commission, the EU’s executive body based in Belgium, reported in July 2024 that the score for access to electronic health records climbed from 72% in 2023 to 79% in 2024. Consequently, the growing prevalence of digital health records is acting as a catalyst for the generative artificial intelligence (AI) in medicine market.

Generative AI In Medicine Market Segmentation Insights: How Is The Industry Categorized?

The generative AI in medicine market covered in this report is segmented –

1) By Component: Solutions, Service

2) By Function: Virtual Nursing Assistants, Robot-Assisted AI Surgery, Administrative Process Optimization, Medical Imaging Analysis

3) By Application: Medical Imaging, Drug Discovery, Medical Diagnosis, Patient Data Analysis, Other Applications

4) By End-User: Hospitals And Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers, Other End-Users

Subsegments:

1) By Solutions: Diagnostic Tools, Treatment Planning Systems, Personalized Medicine Platforms, Drug Discovery And Development Solutions, Medical Imaging And Analysis Software, Electronic Health Record (EHR) Enhancement Tools

2) By Services: Consulting Services, Implementation And Integration Services, Training And Education Services, Technical Support And Maintenance, Research And Development Services.

Generative AI In Medicine Market Trends Explained: What Is Changing And Why It Matters

Major companies operating in the generative artificial intelligence (AI) in medicine market are focused on developing innovative technologies, including AI solutions for brain health and wellness, with the aim of advancing cognitive assessment, improving patient care, and enhancing overall mental health management. AI solutions for brain health and wellness are sophisticated artificial intelligence technologies designed to evaluate, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company dedicated to developing AI-powered digital therapeutics, launched CERVAI, which is the first AI solution for human mental health and wellness. This innovative solution leverages advanced artificial intelligence to comprehensively evaluate cognitive function and brain wellness. Its key features include cutting-edge algorithms that analyze diverse data inputs, such as cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, thereby enabling the early detection of cognitive issues and tailored interventions.

Generative AI In Medicine Market Competitor Landscape: Who Are The Major Companies?

Major companies operating in the generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI Inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI Inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

See The Full Generative AI In Medicine Market Report For Complete Market Sizing And Trends:

https://thebusinessresearchcompany.com/report/generative-ai-in-medicine-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Generative AI In Medicine Market Regional Demand Analysis And Leading Geography

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative AI in medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model